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Abstract
Background:Breast cancer affects over one million women annually and is the most
common global malignancy among women. Extensive improvements have taken
place in the management of breast cancer in recent years and a higher percentage of
women are cured from this disease. A proper assessment of the quality of life of
women with breast cancer is an essential component in disease management. The
Functional Assessment of Cancer Therapy- Breast Symptom Index has been commonly
used and well-validated among English speaking populations as well as other
populations. To date, no formal translation and evaluation of the Functional Assessment
of Cancer Therapy-Breast System Index exists in Arabic. Therefore, this study intends
to translate, adapt and face-validate the Functional Assessment of Cancer Therapy-Breast
System Index into Arabic, specifically in the context of the Lebanese culture. 
Methods: We conducted forward and backward translation in Arabic, combined with
face validity by clinicians. This was followed by pre-testing to ensure the instrument’s
adequacy and cultural sensitivity conducted by the administration of face-to-face
interviews with individual breast cancer patients (n=33) and two focus groups (4
women/group) to evaluate the relevance and appropriateness of each item and words
used in the questionnaire. 
Results: Study results reinforced the value of the Arabic translated version of the
Functional Assessment of Cancer Therapy-Breast System Index in capturing the
quality of life of women with breast cancer in Lebanon.  
Conclusion: The instrument was perceived to be adequate, appropriate for use,
culturally sensitive, simple as well as exhaustive. Suggestions have been made to enrich
the instruments’ ability to incorporate other quality of life dimensions not captured, as
well to enhance the cultural specificity of the Functional Assessment of Cancer
Therapy-Breast System Index, when administered among Lebanese women diagnosed
with breast cancer who are specifically beyond therapy.
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Introduction
Breast cancer affects over one million women
annually. It is the most common malignancy
among women globally, including Lebanon.
Extensive improvements have taken place in the
management of breast cancer in recent years and
a higher percentage of women are cured from
this disease. A proper assessment of the quality of
life (QOL) of women with breast cancer is an
essential component in disease management. The
availability of standardized instruments to assess
the QOL of women with breast cancer is lacking
among Arabic speaking nations. Given the current
burden of breast cancer in the world as well as in
the Middle East, the need for such tools becomes
extremely crucial. 
In Lebanon, breast cancer constitutes more
than one-third of all female cancers. It is the
second leading cause of cancer mortality among
Lebanese women. According to the Lebanese
Ministry of Public Health (MoPH), the crude
breast cancer incidence rate in 2013 was 86.9 per
100,000 females and the overall age standardized
rate (ASR) by using the total world population as
a reference was 78.8 per 100,000.1
Given this high breast cancer burden in
Lebanon, the operationalization and assessment of
QOL among women post-diagnosis with the
disease becomes essential. It also requires well-
validated instruments that are short and easy to
both score and interpret, as well culturally relevant
and disease-specific.2,3
It has been well noted that the availability of
valid QOL instruments that are culturally and
linguistically sensitive improves doctor-patient
communication.4-7 According to a randomized
clinical trial by Detmar et al. in 2002, the
intervention physicians because of their ability to
assess QOL were able to identify more problems
with patients that pertained to concerns with daily
living, feelings, social activities, pain, and fatigue
compared to the control group physicians who
were only able to identify problems related to
daily activities and pain.8 This better
communication resulted in higher satisfaction
among patients in relation to their overall mental
health (reduction of anxiety), role functioning,
and quality of care that resulted in fewer complaint
visits as a result of the perceived emotional support
obtained during communication with the
physician.  
The availability of standardized QOL tools
allows for the evaluation of clinical interventions
designed to enhance clinical and mental health
outcomes among women who suffer from breast
cancer.7-11
In Middle Eastern communities including
Lebanon, many social, cultural and religious
factors interplay to either improve or aggravate
breast cancer morbidity.  Such factors can lead to
poorer prognosis as well as poorer QOL. They
may also hinder women from taking advantage of
screening opportunities and early disease
detection, and also quite likely hinder women’s
compliance with treatment regimens which can
lead to reduced coping and adjustment abilities
among those affected with breast cancer.12 These
poor outcomes can be attributed to fear from both
a positive diagnosis as well as a possible stigma
based on the assumption that the disease is a
punishment for some life transgression that may
accompany such diagnosis.13 These religious /
cultural / ethnic practices specific to this region14
can also improve, as already indicated, the QOL
of women with breast cancer. It has been suggested
that religion and culture affect the way groups
reflect their perceptions of reality and the world
around them.15 Religion usually plays a conducive
role in the management of illness because it gives
meaning to the maintenance of health and care
practices.14,15
It remains unclear how social, economic,
cultural, and religious factors, among others,
interplay differently to affect QOL of women
diagnosed with breast cancer, particularly when
comparing Western to Middle Eastern societies.
One main reason attributed to the lack of such
understanding is the lack of availability of
standardized, adequately validated instruments
to document these differences. 
To date around 21 QOL instruments have been
used in various research assessments of the breast
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cancer population, among which is the Functional
Assessment of Cancer Therapy-Breast Symptom
Index (FACT-B). None of these QOL instruments
serve as a gold standard for the assessment of
QOL among breast cancer patients7 and none
have been validated into Arabic.
The FACT-B questionnaire is a multi-
dimensional tool for the assessment of QOL. It is
made up of the Fact-General (FACT-G) and
supplemented by a Breast Cancer Subscale (BCS).
It consists of 44 self-reported items16 distributed
among approximately four general subscales:
physical well-being (PWB), social/family well-
being (SWB), emotional well-being (EWB), and
functional well-being (FWB) as well as a fifth
BCS. The BCS specifically measures breast cancer
related symptoms and concerns such as arm
swelling and tenderness.17
The FACT-B questionnaire is characterized
by its emphasis on patients' values as well as
brevity. It has been translated into 17 different
languages: English, French (appropriate for use in
Canada, France, and Belgium), German
(appropriate for use in Germany, Austria, and
Switzerland), Italian, Norwegian, Dutch, Swedish,
Spanish, Japanese, Hebrew, Czech, Hungarian,
Danish, Slovak, Chinese-Taiwan/Hong Kong,
Indian and Korean.17-20 It is also known to have
adequate psychometric properties in terms of
reliability, validity, and sensitivity to change in
clinical status over time. FACT-B has been shown
to depict QOL differences among different disease
stages as well as different treatment protocols. The
internal consistency of FACT-B has been reported
in the order a total alpha coefficient (α) of 0.90,
accompanied with subscale α coefficients that
ranged from 0.63 to 0.86. The test re-test reliability
correlation coefficient score was reported in the
order of r = 0.85.17-21
The current study aimed to translate, adapt
and face-validate FACT-B into formal Arabic in
the Lebanese context. This adaptation/translation
process combined both quantitative interviews
as well as focus groups with women diagnosed
with breast cancer. In this paper, we described the
results observed from both assessments and
highlighted the strengths and weakness that
pertained to FACT-B when administered among
Lebanese women with breast cancer.
Materials and Methods
Study design
The study consisted of three phases: translation,
quantitative pilot testing and focus groups. 
The first phase of the study involved both
forward and backward translation of the FACT-B
questionnaire from English to Arabic and vice
versa. This was done by a clinical psychologist,
a social worker and a nurse. All had previous
experiences with translation and were bilingual.
Of note, translation and back translation were
checked by the research team that consisted of an
oncologist, an epidemiologist, and a nurse for
accuracy. All terminology used by the translation
team were accepted. 
The second phase of this study involved pre-
testing the Arabic translated FACT-B by
conducting a series of hospital-based face-to-face
interviews with female survivors of breast cancer
who attended private clinics and outpatient
department (OPD) clinics of the Oncology /
Hematology Clinic at American University of
Beirut-Medical Center (AUB-MC). Both the
private clinics and OPD were intentionally chosen
to balance socio-economic status differences. 
Following pre-testing, the third phase of study
included conducting two focus group discussions
with a total of four women in each focus group.
These focus groups aimed to cross-validate the
results obtained during the interviews and to
create the final FACT-B format in Arabic. 
Participants
For this pilot study a convenient sample of 33
breast cancer women performed the face-to-face
interviews and 8 additional women participated in
the focus groups. Only women who were aware
of their breast cancer status and willing to talk
about it were selected. The target population for
both approaches (face-to-face interview and focus
group) were Lebanese females who met the
following inclusion criteria: breast cancer
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Table 1. Overall Distribution of FACT- B responses (n=33).
Mean ±SD, Median, Mode
(Min-Max)
Fact-B total score1 57.6±15.7, 54.5, 41
(33-92)
Physical well-being (PWB) subscale2 8.7±4.5, 9, 9
Lack of energy (1-18)
Nausea
Difficulty in meeting family needs
Pain
Bothered by treatment side effects
Feeling ill
Forced to spend time in bed
Social well-being (SWB) subscale3 9.3±4.7, 10, 12
Feel close to my friends (5-10)
Get enough emotional support from family
Get enough support from friends
Family accepted my illness
Satisfied with family communication about my illness
Feel close to my partner
Satisfied with my sexual life
Emotional well-being (EWB) subscale4 7.2±4.5, 6, 4
Feel sad (0-18)
Satisfied with the way I am coping with my illness
I am losing hope in the fight against my illness
I feel nervous
I worry about dying
I worry that my condition will get worse
Functional well-being subscale (FWB)5 12±4.6, 11, 7
I am able to work (including work at home) (4-23)
My work (including work at home) is fulfilling
I am able to enjoy life
I have accepted my illness
I am sleeping well
I am enjoying the things I usually do for fun
I am content with the quality of life right now
Additional concerns subscale6 23.3±6.2, 24, 15
I have been short of breath (15-35)
I am self-conscious about the way I dress
One or both of my arms are swollen or tender
I feel sexually attractive
I am bothered by my hair loss
I worry that other members of my family will get the disease
I worry about the effect of stress on my illness
I am bothered by the change in my weight
I am able to feel like a woman
I have certain parts of my body where I experience pain
Results for all scores are the non-weighted sums of the individual questions for the total score, and for each individual subscale. For the total result and
all subscale results, the higher scores reflect worse reported quality of life (QOL). 
1: 37 questions (lowest score = 0; highest score = 148).
2: 7 questions (lowest score =  0; highest score = 28).
3: 7 questions (lowest score = 0; highest score = 28).
4: 6 questions (lowest score = 0; highest score = 24).
5: 7 questions (lowest score = 0; highest score = 28).
6: 10 questions (lowest score = 0; highest score = 40).
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Table 2. Descriptive characteristics of participants (n=33).
A Socio-economic status (SES) Mean ± SD (range)
Age (years) 47.2 ± 11.8  (20-71)
Age categories (years) N (%)
20-39 4 (12.1)
40-49 17 (81.8)
50-71 2 (6.1)
Marital status N (%)
Single 4 (12.1)
Married 17 (81.8)
Widowed 2 (6.1)
Educational status N (%)
Intermediate or below 8 (25)
High school/vocational 12 (37.5)
University 12 (37.5)
Occupational background N (%)
Teacher/accountant/secretary 10 (32.3)
Nurse/physical therapist/social worker 3 (9.7)
Shopkeeper/other 6 (19.4)
Never worked 12 (38.7)
Monthly salary (US$) N (%)
<900 9 (28.1)
1000-3000 11 (34.4)
>3000 3 (9.4)
Don’t know/no answer 9 (28.1)
Smoking status N (%)
Cigarettes
Current 8 (24.2)
Previously 7 (21.2)
Never 18 (54.5)
Water pipe smoking
Current 3 (9.1)
Previously 7 (21.2)
Never 23 (69.7)
B Reproductive history Mean ± SD (range)
Age (years)_at first marriage 20.12 ± 937 (0-36)
Age (years) at first pregnancy 18.8 ± 11.6 (0-41)
Total number of pregnancies 3.33 ± 2.5 (0-10)
Yes- N (%)
History of lactation 21 (63.6)
Use of oral contraceptive pill (OCP) 7 (21.2)
Use of Hormone Replacement Therapy (HRT) 4 (12.5)
C Family history Yes- N (%)
Mother had breast cancer 4 (12.1)
Sister had breast cancer 3 (9.1)
Daughter had breast cancer 0 (0)
Father had breast cancer 0 (0)
Grandmother on the mother’s side had breast cancer 0 (0) 
Aunt on the mother’s side had breast cancer 2 (6.1)
Grandmother on the father’s side had breast cancer 0 (0)
Aunt on the father’s side had breast cancer 2 (6.1)
D Diagnosis and disease management N (%)
Disease TNM stage at diagnosis
Stage I 7 (21.2)
Stage II 10 (30.3)
Stage III 6 (18.2)
Stage IV 5 (15.2)
Don’t know 5 (15.2)
Therapy status N (%)
Ongoing 28 (87.5)
Finished 4 (12.5)
Disease management Yes- N (%)
Surgery 26 (81.3)
Chemotherapy 31 (93.9)
Radiotherapy 24 (72.7)
Hormonal therapy 15 (45.5)
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diagnosis, patients followed by the AUB-MC
oncology clinics, were aware of their diagnosis,
were willing to share their experiences, and signed
an informed consent to participate in the study.
Recruitment strategies and techniques
After securing the approval of the Institutional
Review Board of the American University of
Beirut, ethical approval of the AUB-MC and
consent of the treating physicians, we recruited
women from either the private clinics or out-
patient department clinics of the Oncology/
Hematology Clinics. 
Recruitment employed advertisements were
displayed on the bulletin boards of the
Hematology/Oncology Clinics. Women were
approached by a trained research assistant who
explained the purpose of the study and presented
a request to join the study.
Only women providing consent were selected
for the interviews and the focus groups.
Two types of informed consent were used, as
the study involved two phases of data collection:
pilot test interviews and focus groups. The
informed consents for both the interviews and
the focus groups were obtained from each woman
in a private separate room prior to their study
participation. The consent forms were
administered in Arabic and explained the purpose
of the study (pre-testing of FACT-B in Arabic).  In
seeking consent, it was ensured that the woman
felt at ease to refuse or to accept to take part in this
study, as well as to ask questions or clarifications.
Issues of confidentiality and willingness to stop
the interview at any time, even after giving
consent, as well as the risks and the benefits were
all clearly highlighted. 
Data collection
Face-to-face interviews
Data collected consisted of both close ended
face-to-face interviews as well as focus groups.
The face-to-face interviews ranged between 15-
20 minutes.  They were undertaken by the research
assistant on this project following informed
consent and administered in form of a
questionnaire. The questionnaire consisted of 44
questions, divided over six different sections.
The first five sections consisted of questions that
cover the following QOL dimensions of FACT-B:
PWB, SWB, EWB, FWB and additional concerns
pertaining to breast cancer. Table 1 shows the
description and distribution of each of the
subscales along with the overall total instrument
score.
The last section inquired about various socio-
economic characteristics of the women and
disease-related questions.  These included: age,
marital status, education, occupation, smoking
history, reproductive history and disease-specific
questions such as stage of diagnosis, therapy
status, and type of therapy (Table 2). At the end
of the interview, the women were also asked to
indicate which questions they considered most
relevant and whether or not any additional
questions or concerns needed to be incorporated.
They were also asked to rate the overall degree of
complexity of the FACT-B.
Focus groups
Two focus groups were conducted with women
who were breast cancer survivors, from the same
clinics who did not participate in the interviews.
Women selected in each of the focus groups were
asked to come for only one visit to conduct the
focus group.  The scheduling of the focus groups
was ensured to be at a time of convenience to the
participating women. The focus groups were run
by a moderator with extensive experience in
qualitative methodology. 
The two focus groups took place on two
different days. For each group, 8 to 10 women
were invited but only four from each group
responded and attended the meeting. At the
beginning of each meeting, the moderator
explained the purpose of the study. To prevent
socially pleasing answers, the moderator
emphasized that there were no right or wrong
answers, and that all answers were important for
eliciting feedback on the tool. The language used
in the focus groups was the native language of the
participants, which was Arabic. Of note, during the
focus groups the Arabic translated Fact-B version
was used (see translation process earlier).
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When evaluating the performance of FACT-B,
women who completed therapy tended to have
better scores. FACT-B scores were better for
women who did not have surgery compared with
those who did. Similar trends were observed
among women who received radiotherapy and
hormonal therapy. FACT-B scores were lower
for women who were administered chemotherapy
(Table 3). None of these observed differences
reached statistical significance.
The focus groups began by asking each
participant to choose a pseudo name and sign an
informed consent. Surprisingly, all participants
decided to keep their original names, stating that
they were happy to share their experiences and
feedback with others and that they were not
ashamed of what they were doing. The patients all
emphasized that their primary aim behind
participating in these focus groups was to share
their experiences to help other women with breast
cancer. 
The focus group framework centered on
evaluating the subcomponents of FACT-B
including the individual questions. The participants
were asked to give their feedback on the pertinence
of the questions posed across their experiences
with breast cancer. They were also requested to
give feedback about the terminology used and
the level of comprehensibility of the questions. 
Data analysis
Two types of analyses were made. The first was
the interviews’ analysis which included descriptive
and bivariate analyses. The descriptive analysis
included the mean, standard deviation (SD) and
ranges for continuous variables and frequency as
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Table 3. Performance of FACT-B with disease-related management.
FACT-B Therapy Surgery Radiotherapy Chemotherapy Hormonal           Willing to take
Categories Status therapy part in an 
(Finished vs intervention 
Ongoing) to improve 
quality of life
Mean±SD           Mean±SD Mean±SD Mean±SD Mean±SD Mean±SD
Total score1
Yes 75.2± 14.9 72.8±14.8 74±13.3 73.1± 13.3 76.7±16.1 73.6± 13.1
No 72.7± 13.9 76.2± 10.2 71.8± 15.9 78.5±27.6 72.1± 10.9 72.3±18.0
Physical well-being (PWB) subscore2
Yes 10.7±54.3 7.9± 3.9 8.8± 4.9 8.7±4.7 7.8±5.2 8.4± 4.4
No 8.2± 4.6 12.8± 4.5 8.3± 3.7 9± 0.0 10.1±3.5 7.67±5.0
Social well-being (SWB) subscore3
Yes 23± 4.2 21.1± 4.2 21.4± 4.7 20.9± 4.5 22.2± 4.6 20.5±4.4
No 20.9± 4.6 20.8±6.1 20.7± 4.0 25.0±1.41 20.6± 4.4 21.8±3.6
Emotional well-being (EWB) subscore4
Yes 7± 2.9 6.4± 3.3 6.5± 4.0 6.4± 3.6 7.5±4.5 6.7±3.3
No 6.4± 3.7 7.8±3.6 6.5±1.9 8.0± 1.4 5.7±2.2 6.3±4.8
Functional well- being (FWB) subscore5
Yes 18.7± 4.8 18.8± 4.2 18.6± 4.3 18.4±4.3 19.8± 3.3 18.4± 3.4
No 18.4± 4.3 15.8± 3.9 17.8± 4.2 18.0± 1.4 16.6± 4.3 20.7± 3.7
Additional concerns subscore6
Yes 26±9.9 24.1±6.8 23.9±5.9 24.3±6.04 27.3± 5.7 24.8±6.4
No 24.5± 6.5 29.6± 1.1 28.4± 7.7 37.±0 22.4± 6.7 25.6± 4.9
Results for all scores are the non-weighted sums of the individual questions for the total score, and for each individual subscale. For the total result and
all subscale results, the higher scores reflect worse reported quality of life (QOL). 
1: 37 questions (lowest score = 0; highest score = 148).
2: 7 questions (lowest score =  0; highest score = 28).
3: 7 questions (lowest score = 0; highest score = 28).
4: 6 questions (lowest score = 0; highest score = 24).
5: 7 questions (lowest score = 0; highest score = 28).
6: 10 questions (lowest score = 0; highest score = 40).
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well as the percentage distribution for categorical
variables. The bivariate analysis used the chi-
square test of association, set at a 5% type I error
as well as the independent sample t-test and
ANOVA, also set at a 5% type I error. The purpose
of the bivariate analysis was to check if the
instrument could depict differences for stage of
diagnosis, therapy status, type of therapy, and
socioeconomic background.  This analysis was
conducted using the Statistical Package for Social
Sciences (SPSS) version 19.
The second type was the focus groups’ analysis,
which involved transcribing, analyzing, and
assimilating obtained data from the focus groups.
To ensure validity and reliability, the researchers
made sure to maintain stability, equivalence and
internal consistency of the data.22 These three
criteria were guaranteed respectively through the
following approaches: consistency of issues
discussed over time, breast cancer as the common
trait for all group members, and one moderator
who led the discussion with both groups and
played a dominant role in data analysis. The
moderator played the role of the group facilitator
and did not interfere in the participants'
discussions. Moreover, the moderator incited
participants to give more in depth feedback
through probing techniques.
Results
Quantitative assessment
A total of 33 women were administered the
FACT-B for pilot-testing purposes. The average
age of the women was 47.2±11.8 years, with
12.1% in the 30-39 year age group. This was
similar to the Lebanese national mean age of 50
years at the time of diagnosis with breast cancer.
The majority of the women were married. The
sample consisted of fairly educated, currently
employed women.  The average monthly income
for the majority of these women was below 1000
US dollars. A total of 44.5 % of the women were
current or past cigarette smokers and 30.3% were
current or past smokers of the water pipe.
As far as the participants’ reproductive and
family history, the average age of the first marriage
was 20±9.4 years, average age of first pregnancy
was 18±11.6 years, and average number of
pregnancies was 3.3. Of participants, 63.6%
indicated that they have breastfed, 21.2% used oral
contraceptive pills (OCPs) and 12.5% indicated
that they were on hormone replacement therapy
(HRT) prior to breast cancer diagnosis.
Participants whose mothers had breast cancer
comprised 12.1% of the women, 9.1% had a sister
with breast cancer, 6.1% had an aunt from the
mother’s side and 6.1% stated they had an aunt
from the father’s side with breast cancer. In terms
of immediate family members, 15% indicated
they had one immediate family member with
breast cancer and 9% stated they had two
immediate family members with breast cancer.
As far as disease diagnosis and management,
the sample was fairly balanced across the different
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Table 4. Performance of FACT-B with disease TNM stage at initial diagnosis.
FACT-B categories Do not know Stage I Stage II Stage III Stage IV
Mean±SD Mean±SD Mean±SD Mean±SD Mean±SD
Total score1 74.6±11.34 73.8±15.9 74.2±16.9 70.7±11.7 66.8±7.2
Physical well-being (PWB) subscore2 8.2±6 10.1±5.1 7.4±3.6 9.7±2.5 7.6±6.3
Social well-being (SWB) subscore3 20.2±3.9 20.3±3.3 22.7±4.8 20.7±3.3 18.0±5.6
Emotional well-being (EWB) subscore4 5.8±1.6 7.6±4.9 6.3±3.8 5±1.7 7±3.9
Functional well-being (FWB) subscore5 19.2±3.9 18.7±4.3 19.7±3.9 14.2±4.9 18.5±4.4
Additional concerns subscore6 23.0±4.9 26.6±5.0 27.1±6.0 19.7±6.7 21.7±6.4
Results for all scores are the non-weighted sums of the individual questions for the total score, and for each individual subscale. For the total result and
all subscale results, the higher scores reflect worse reported quality of life (QOL). 
1: 37 questions (lowest score = 0; highest score = 148).
2: 7 questions (lowest score =  0; highest score = 28).
3: 7 questions (lowest score = 0; highest score = 28).
4: 6 questions (lowest score = 0; highest score = 24).
5: 7 questions (lowest score = 0; highest score = 28).
6: 10 questions (lowest score = 0; highest score = 40). 
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disease stages at initial diagnosis - approximately
50% had stages I or II and the other half had
stages III or IV (Table 4). The majority of women
were undergoing therapy at the time of the
interview. Most underwent surgery to manage
the disease as well as radiotherapy and
chemotherapy. Hormone therapy for disease
management was administered to 45.5% of the
total population (Table 2).
In terms of the performance of the instrument
according to disease stage results revealed that,
generally, FACT-B had better scores for women
with stages I/II cancer compared to those with
stages III/IV. Possibly the tool could depict
differences in QOL according to disease extent
(Table 4). The same trend was generally observed
for the different subscales of FACT-B. There was
no statistical significance, which could be mainly
attributed to the limited sample size.
Younger women had better FACT-B scores
than older women. Women with higher
educational level had lower FACT-B scores which
means better quality of life. Women with an
average salary income >3000 US$ also had better
FACT-B scores (Table 5). Again, there was no
statistical significance observed.
When evaluating responses to individual
questions by respondents, the following items
were rated as inapplicable for PWB: nausea and
bothered by treatment side effects; SWB: sex life,
feeling sad; FWB: my work (including work at
home is fulfilling, I enjoy the things I do in life);
and additional concerns: shortness of breath, self-
consciousness about the way to dress, having
swollen or tender arms, feeling sexually attractive,
hair loss and feeling like a woman.
When inquired of whether or not the women
had any comprehension difficulty pertaining to the
questions and the associated complexity of FACT-
B, all respondents indicated that the questions
Middle East J Cancer 2014; 5(3): 151-165 159
Table 5. Performance of FACT-B with socio-economic background characteristics.
Total score1 Physical well- Social well- Emotional well- Functional well- Additional
being (PWB) being (SWB) being (EWB) being (FWB) concerns
subscore2 subscore3 subscore4 subscore5 subscore6
Age Mean±SD Mean±SD Mean±SD Mean±SD Mean±SD Mean±SD
(years)
20-39 75±17.8 8.1± 3.3 19.1± 5.7 7.3± 3.6 19.1± 5.1 25.7± 7.6
40-49 76.1±15.1 8.5±4.8 21.8± 3.4 6.4± 3.2 17.3± 4.5 25.4± 7.1
50-71 69.2±10.8 9.5± 4.9 22.1± 4.5 7.1± 3.7 18.9± 3.6 23.0± 5.9
Education
Intermediate or below
75± 12.3 11±4.4 19.4± 3.1 7.1±2.9 17.7± 3 26.2±7
Vocational/high school
73.8 ±16.9 6.9± 4.2 21.7± 3.5 6.4± 4 19±3.6 25.1± 6.7
University
72.3 ± 12.9 8.8±4.7 22.8± 5.2 6.2±3.8 18.8± 5.4 23.1± 6.5
Salary (monthly- US$)
<1000
75.7±17.4 7.5 ±3.4 22± 3.4 6.5±2.6 18.8± 3.2 26.1± 8.2
1000-3000
69.8 ± 12 8.3±4.3 21.3± 5.6 5.3± 3.9 17.4± 4.4 22.4± 6.8
>3000
89.7±7.1 10±6.9 23.3 ±2.3 8.7± 5.7 19.7± 4.9 28.0±3.6
Results for all scores are the non-weighted sums of the individual questions for the total score, and for each individual subscale. For the total result and
all subscale results, the higher scores reflect worse reported quality of life (QOL).
1: 37 questions (lowest score = 0; highest score = 148).
2: 7 questions (lowest score =  0; highest score = 28).
3: 7 questions (lowest score = 0; highest score = 28).
4: 6 questions (lowest score = 0; highest score = 24).
5: 7 questions (lowest score = 0; highest score = 28).
6: 10 questions (lowest score = 0; highest score = 40).
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used were fairly simple, linguistically appropriate
and culturally sensitive. 
Qualitative assessment
Demographics of women who participated in
the focus groups paralleled those who participated
in the face-to face interviews. Findings from both
focus groups showed concordance in terms of
the obtained feedback between groups on all
categories and questions of FACT-B.
Physical well-being (PWB)
All participants agreed that the questions were
well formulated and clear. When asked to rank the
questions in priority order, the items related to
“pain” and “meeting the needs of my family”
were ranked first. Participants dwelt on the item
related to “spending time in bed” and mentioned
that it was only natural to be in bed if one took pain
medication. Therefore, it was not considered to be
an important question. When asked if the questions
were satisfactory or if they wanted to add a new
question, some participants mentioned that they
would like to add an item related to social visits
after the treatment. Some emphasized the above
point by stating that they do not like to receive
visits after treatment because of the noise and
need to rest. On the contrary, others mentioned that
they would like to be surrounded by people and
receive visits at all times. Another suggested a
question related to the change in taste because of
treatment. Participants felt that this section was
more pertinent to the period during which they
were receiving chemotherapy. They also agreed
that during post-treatment, the most important
question for them was related to side effects,
which might continue even after the treatment
was finished. 
Social/family well-being (SWB/FWB)
All participants agreed that the questions were
very clear. They also mentioned that none were
embarrassing, including those related to sexual life.
Participants suggested splitting the question G86
related to “being close to the partner” into “partner
and significant other", because some of them
were widowed or not married. To them “partner”
meant “husband”. The most important question for
them was GS2, “I get emotional support from
my family”. The family support was emphasized
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Table 6. Consensus on the different FACT-B items pertaining to the different sub-components: Summary of the quantitative &
qualitative results.
FACT-B Sub-categories Most relevant/ Not relevant/ To be added
important indifferent/not applicable
Physical well-being -Ability to meet the needs -Staying in bed (only relevant -Social visits 
(PWB) subscore of my family Pain during treatment) during treatment
-Side effects post treatment - Changes in taste
-Nausea during treatment
Social well-being -Emotional support -Informing friends -Being close to partner
(SWB) subscore from family or other family members to be split into: 
-Sex life -  Spouse
- Significant other
Emotional well-being -Worry that my -Feeling sad - Timing of when to
(EWB) subscore condition will administer the interview
get worse -Feeling Nervous
Functional well-being 
(FWB) subscore -Sleeping well - Shortness of breath -Pity
Additional concerns -Worry that other family
subscore members will get the disease - Self-conscious -Financial aspect of the disease
-Change in weight about the way to dress
- Hands swollen or tender - Doctor-patient interaction
-Pain in different  -Feeling sexually attractive
body parts -Hair loss - Feeling like a woman
Face Validity of FACT B into Formal Arabic
as a very important aspect to be able to cope with
the disease. While discussing friend support, some
participants stated that they did not tell their
friends about their disease. Some did not inform
their extended family members and only the
members of their nuclear family were aware of
their diagnosis. Therefore, it was suggested to
add an item that asks whether they have revealed
the information to their friends/extended family
members. 
Emotional well being (EWB)
Again, participants reported that all words and
ideas were clear. When asked to identify the most
important question, most women alluded to GE6,
“I worry that my condition will get worse”. When
asked to highlight the least important question they
mentioned that GE1 and GE4, which talked about
“being sad and being nervous” were the same.  In
fact, they considered that each of the questions
triggered or led to the other. Hence, the women did
not see the need for having both. However, they
stressed that some surrounding environmental
factors could trigger those feelings of sadness
and nervousness like hearing nice music during
sunset or in the afternoon or at night. So the
timing of administering this section of the
questionnaire was an important factor to consider.
Most participants mentioned that all questions in
this section were equally important. All concepts
in the section seemed to be important for women’s
EWB. 
Functional well-being (FWB)
All words and ideas were reported as clear in
this section. Participants again mentioned that all
questions adequately reflected their FWB. The
most important item with the greatest impact on
their FWB was GF5, “I am sleeping well”. Sleep
was highlighted as an important factor. All
participants debated the importance of sleep on the
well-being of the individual. Some reported lack
of sleep because of pain and others as a result of
some haunting ideas that prevented them from
sleep.
Additional concerns
Participants reported that all questions were
comprehensible. The most important items in this
section was “the worry about the family members
from getting the disease”, “the change in weight”
and “pain” in the different parts of the body.
When asked whether or not they perceived that this
tool covered all aspects of their life in relation to
their disease, the participants mentioned two items
not available in the tool that seemed to be vital for
them. They all talked about the way others looked
at them, or dealt with them and they specifically
mentioned “pity”. Another emphasized item was
related to the financial aspect of treatment.
Convergence of quantitative and qualitative
assessments
The results of the quantitative assessment
(interviews) converged with many of those
observed during the qualitative assessment (focus
groups), in terms of the perceived: important
questions, irrelevant/unimportant questions and
questions that needed to be added. 
In general, the following questions were
perceived to be most important: ability to meet the
needs of my family, pain, emotional support,
worry that my condition will get worse, sleep,
worry that other family members will get the
disease, change in weight, and pain in different
areas of the body. Irrelevant or inapplicable
questions included: staying in bed (only relevant
during treatment), informing friends or other
family members about their disease, feeling sad,
feeling nervous, shortness of breath, self-conscious
about the way to dress, hands swollen or tender,
feeling sexually attractive, hair loss, and feeling
like a woman. Questions suggested to be added
included: nuisance of repeated social visits during
treatment, changes in taste during treatment, being
close to partner which should be divided into
partner or significant other, timing of when to
administer the interview, pity, financial aspect of the
disease, and doctor-patient interaction (Table 6).
Discussion
Results from this face-validity study of the
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Arabic translation of the FACT-B questionnaire
indicated that for most of its subcategories, the
instrument adequately tackled the different aspects
that could possibly affect QOL of women with
breast cancer. In both the qualitative and
quantitative assessments, the instrument was
considered easy to follow, short, simple, culturally
appropriate and pertinent to the women’s
experience with the disease.
The interview questionnaire revealed that
FACT-B, when delivered in Arabic, had a good
ability to distinguish QOL status with respect to
whether or not the women were undertaking or
finished treatment, disease stage at initial
screening, and disease management (surgery,
radiotherapy, hormonal therapy and
chemotherapy). Women had better QOL outcomes
when their disease management was surgery,
radiotherapy and hormonal therapy compared to
chemotherapy. The instrument was also able to
depict that younger women and those with higher
monthly incomes had better QOL outcomes.
As indicated above, the results of the
quantitative assessment (interviews) paralleled
many of those observed during the qualitative
assessment (focus groups) in terms of perceived
important questions, irrelevant/unimportant
questions and questions that needed to be added.
Respondents agreed that the FACT-B
questionnaire was more reflective of QOL during
disease management/therapy as opposed to post-
treatment. This agreed with a number of available
literatures on FACT-B as it was specifically
designed to assess QOL of breast cancer patients
during disease management/therapy.16,17
Our findings were comparable to literature
published elsewhere regarding FACT-B translation
in other languages/settings. Husband’s support
was a relevant theme observed in the current
study as well as other studies.23
The fact that sexuality and feminine-related
issues were perceived by the women as
unimportant or were left unanswered could
indirectly suggest that women could be possibly
worried about these aspects, yet, at the same time
not comfortable enough to disclose them in front
of others. A study has estimated that 25%-33% of
women experience problems with femininity and
sexuality after a year following mastectomy.24
One woman in our study during one of the focus
groups actually noted that she had feelings of
guilt towards her husband.  Mastectomy and hair
loss, as it seems, were the main sources for this
fear. Not only the husband, but the society at
large has imposed a certain stigmatization on
women who have undergone mastectomy and
lost their hair.25,26
In general, society places heavy pressures on
women’s overall physical appearance. Many
women try to hide their condition to prevent
stigma and preserve their identity.27 For example,
one woman in our study explained that in spite of
the fact that she wore a head cover to hide her hair
loss, people were still bothered and commented
on her pale color. Also, the majority of the women
in the focus groups indicated being bothered by
people’s looks. The fact that many women left the
femininity and sexuality questions in our study
unanswered reflected the cultural influence as
reported in other cultures.23,28 In a very few other
cultures, however, women acted indifferent to
their appearance to teach society to accept their
condition.29
Family, friends and neighbors was a relevant
theme in this study and in other studies cited in the
literature.24,30 The women worried about their
immediate surroundings at many levels: emotional,
psychological, physical as well as social in terms
of meeting certain obligations. In our study,
“meeting the needs of my family” was one of the
highest priority items in FACT-B according to
the women in the focus groups. Women were
also concerned about hiding their distress and
agony about the disease from their family, which
was supported by another study conducted in
Lebanon by Doumit et al.26 on Lebanese cancer
patients who received palliative care. 
Breast cancer patients, according to the
literature, often feel the pressure from their
surroundings to pretend optimism when they are
not actually optimistic.23,25,26,30 The role of the
husband in helping to disclose disease status to
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children and immediate family was perceived as
very important.31
On another note, allowing personal space and
time to rest (especially after therapy) was also
noted to be very significant for women of this
study.  Repeated visits by family or friends were
noted to be a cause of nuisance. The same was
perceived true for offering assistance with the
performance of certain chores that the women
could do by themselves. This introduced feelings
of incapability and reminded women of their
disease.26,31
The role of spirituality in dealing with the
disease was significantly emphasized in our study.
Adding a spirituality component to FACT-B was
noted by the women. One of the women shared
that she continued to wear a veil even after her hair
grew because she felt that God helped her to cope
with her agony. Another woman explained how
praying and reading verses from the Quran
provided her with immediate relief. Women did
not deny that it was their fear that drove them more
towards God, but they also explained that they had
strong beliefs even before diagnosis. Other studies
shared similar results.24,31-33 This contrasted results
of a Canadian study where some women viewed
God as harsh and punitive, and decided not to pray
to Him anymore.34
Fear of disease recurrence was commonly cited
by the women in our study as having an effect on
their overall QOL. This item was not present in
FACT-B. This finding, moreover, has been
commonly shared by studies of women with breast
cancer.26,35,36
When women were asked if whether or not
taking part in a psychosocial intervention could be
conducive to their QOL the majority in the
quantitative assessment answered positively.
However, participants in the qualitative assessment
explained that this could only be conducive if
the intervention did not tackle/speak of their
disease or if they had to share painful details or
agonies experienced by other women. This was
also highlighted in the literature by Simpson,
2005. Finally, two important aspects per the
women in our study that were perceived to affect
QOL and presumed missing in FACT-B were the
role of the doctor-patient relationship and finances.
A good relationship with physicians is often
perceived as instrumental for patients and an
important source for psychological comfort.32,35 In
our study, the women have stated that they were not
satisfied by the way their physicians disclosed their
disease status with them or the ways physicians
explained disease management options and
associated side effects. They also noted that little
time was given to them to interact with their
physician and comprehend the repercussions of
their disease. This contrasted the women's
documented experiences with nurses. The women
explained that the kindness of nurses and their
reinforcing messages significantly helped them to
overcome many of their anxieties. 
In summary, our study results reinforced the
value of the Arabic translated version of FACT-
B in capturing the QOL of women with breast
cancer in Lebanon. The instrument was perceived
to be adequate, appropriate for use, culturally
sensitive and simple, as well as exhaustive.
Suggestions were made to enrich the instruments’
ability to capture QOL in breast cancer patients
after therapy.
This study is characterized by several strengths
which include combining qualitative and
quantitative assessments to ensure a holistic face-
validity exercise, forward and backward
translations by experts with significant experience
in the field, data management and analysis that
have been conducted independently from the
translation process. 
Limitations associated with our study included
the limited sample size, sample selection
comprised of volunteers (hence, more cooperative
women could have participated), and the need to
conduct content and construct validity as well as
reliability assessments. These could have played
a role in affecting the generalizability of the
findings observed in our study. Regional
assessment with other women whose native
language is Arabic and are residents of other
countries in the Middle East and North African
region is also recommended to strengthen the
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conclusions of the findings observed in this study.
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